Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Maravai Lifesciences Holdings (MRVI) Amortization - Deferred Charges (2020 - 2021)

Maravai Lifesciences Holdings (MRVI) has 1 years of Amortization - Deferred Charges data on record, last reported at $2000.0 in Q3 2020.

  • For Q3 2020, Amortization - Deferred Charges changed N/A year-over-year to $2000.0; the TTM value through Jun 2021 reached $2000.0, changed N/A, while the annual FY2020 figure was $19.0 million, N/A changed from the prior year.
  • Amortization - Deferred Charges reached $2000.0 in Q3 2020 per MRVI's latest filing, down from $19.0 million in the prior quarter.
  • Across five years, Amortization - Deferred Charges topped out at $19.0 million in Q1 2020 and bottomed at $2000.0 in Q3 2020.